Miyako Matsumizu - Concepedia

Author

Miyako Matsumizu

Also Known As

M. MATSUMIZU, Miyako Matsumizu

Publications

166

Citations

H-Index

Concepts

All Affiliations

Miyako Matsumizu is an author at Pfizer (United Kingdom) specializing in engineering, chemistry, and organic chemistry.

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	102
2	Medicine	2	2	40
3	Natural Sciences	2	2	98
4	Biomolecular Engineering	2	2	110
5	Biochemistry	1	1	14

Miyako Matsumizu

Publications

142

Citations

H-Index

Page 1

	Year	Citations
Chiral Lewis Acid-Mediated Enantioselective Pictet−Spengler Reaction of <i>N</i><sub>b</sub>-Hydroxytryptamine with Aldehydes Hideki Yamada, Tomohiko Kawate, Miyako Matsumizu, The Journal of Organic Chemistry Enantioselective Pictet-spengler ReactionEngineeringNatural SciencesDiversity-oriented SynthesisPictet-spengler Reaction	1998	84
Optimisation of a novel series of selective CNS penetrant CB2 agonists Christine Watson, Dafydd R. Owen, Denise Harding, Bioorganic & Medicinal Chemistry Letters Cannabis UseCombinatorial ChemistryNovel SeriesFunctional SelectivityMedicine	2011	26
Enantioselective Pictet-Spengler Reaction of Nitrones Derived from <i>N</i><sub>b</sub>-Hydroxytryptamine with Aldehydes Catalyzed by Chiral Brønsted Acid-Assisted Lewis Acids Tomohiko Kawate, Hideki Yamada, Miyako Matsumizu, Synlett Chemical EngineeringEnantioselective Pictet-spengler ReactionEngineeringNitrones DerivedN B-hydroxytryptamine	1997	18
Discovery of novel and orally active NR2B-selective N-methyl-d-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity Makoto Kawai, Hiroshi Nakamura, Isao Sakurada, Bioorganic & Medicinal Chemistry Letters Pyridinol DerivativesBiochemistryFunctional SelectivityMedicineNatural Sciences	2007	14

Page 1